SLC7A11 and neoplasm: In contrast, in non-tumor diseases, chronic microenvironments induce compensatory cystine metabolism imbalance through epigenetic modifications (e.g., NFATc1 activation of SLC7A11), ​​creating conditions that promote pro-inflammatory immune cell infiltration (32–34).